In each issue of
HealthLeaders Magazine, we include an Interview feature with a prominent healthcare executive.
In 2020, the Interview subjects ranged from C-suite healthcare executives to entrepreneurs, innovators, and a former HHS Secretary.
Throughout a chaotic year such as this, the conversations with industry players who are making a difference, and driving the conversation were more important than ever.
Below are the six HealthLeaders Magazine Interview features of 2020:
Clinical Care Editor Christopher Cheney interviewed Shah, a healthcare leader with numerous roles and responsibilities.
Shah is an obstetrician-gynecologist at Beth Israel Deaconess Medical Center, an assistant professor at Harvard Medical School, director of the Delivery Decisions Initiative at Ariadne Labs, and board chair of Costs of Care.
Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, HHS issued a final rule intended to govern the administrative dispute process in the 340B Drug Pricing Program. Read more about the rule and other news below.
I. Regulations, Notices & Guidance
On December 8, 2020, the Food & Drug Administration (FDA) issued guidance entitled,
Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. This draft guidance describes best practices to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and its implementing regulations. The draft guidance also describes the framework FDA uses i